Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Intro to Biopharm and Pharma. Models

Total questions: 50

Worksheet time: 25mins

Name
Class
Date
1.

Biopharmaceutics is best described as the study of:

a)

Receptor binding and post-receptor effects

b)

Factors influencing bioavailability and using them to optimize therapeutic activity of drug products

c)

Kidney excretion via only tubular reabsorption

d)

Drug’s irreversible removal via any mechanism

2.

Which list matches the specified interrelationship studied in biopharmaceutics?

a)

Physicochemical properties, dosage form, route, rate/extent of absorption

b)

Receptor binding, intensity, time course

c)

Glomerular filtration, tubular secretion, tubular reabsorption, bile excretion

d)

Elimination + distribution = elimination

3.

Which of the following is NOT a physical-chemical property?

a)

Particle size

b)

Specific surface area

c)

Hydrophobicity

d)

Polymorphism

e)

Receptor density

4.

Consistent bioavailability is especially important when a drug:

a)

Has a wide therapeutic range

b)

Has a narrow therapeutic range

c)

Is only given IV

d)

Is eliminated only via lungs

5.

Pharmacokinetics is described as:

a)

What the drug does to the body

b)

What the body does to the drug; kinetics of ADME

c)

Only distribution and metabolism

d)

Only receptor binding and post-receptor effects

6.

Which statement matches the definitions given?

a)

Elimination = Distribution + Excretion

b)

Disposition = Metabolism + Excretion

c)

Disposition = Distribution + Elimination

d)

Disposition = Receptor binding + post-receptor effects

7.

Clinical pharmacokinetics involves individually optimized dosing strategies based on:

a)

Only patient age and weight

b)

Patient’s disease state and patient-specific considerations

c)

Only first-pass effect

d)

Only urine monitoring

8.

Pharmacodynamics is:

a)

What the body does to the drug

b)

What a drug does to the body

c)

Irreversible drug removal via kidneys

d)

Dose validation in animals only

9.

Onset of action is the time when:

a)

Plasma concentration falls below MEC

b)

The drug reaches therapeutic range

c)

Cmax is achieved

d)

Elimination ends

10.

In a plasma level vs time curve, MTC and MEC stand for:

a)

Maximum therapeutic concentration; minimum effective concentration

b)

Minimum toxic concentration; minimum effective concentration

c)

Mean tissue concentration; maximum elimination constant

d)

Minimum tissue concentration; minimum elimination concentration

11.

A limitation of tissue biopsy drug concentration is that it:

a)

Cannot indicate presence of drug

b)

Always reflects concentration in all tissues

c)

May not reflect drug concentration in other tissue or all parts of the source material

d)

Is the most direct approach in PK

12.

Drug concentrations in urine are described as an indirect method to ascertain bioavailability because:

a)

Rate/extent excreted indicate rate/extent of absorption

b)

Rate/extent excreted indicate receptor binding

c)

Rate/extent excreted indicate partition coefficient

d)

Rate/extent excreted indicate manufacturing process

13.

Which feature is specifically associated with intravascular administration?

a)

Presence of absorption phase

b)

Absence of absorption phase

c)

Incomplete absorption is expected

d)

Onset/duration strongly influenced by formulation and dosage form type

14.

Which statement is specifically made about intravascular administration?

a)

Used mostly for mild/self-limited disease states

b)

Adverse reactions are difficult to reverse/control; dose calculation/administration accuracy is critical

c)

Entire dose may not reach circulation due to first-pass metabolism

d)

Requires an absorption phase to occur

15.

Which route is NOT extravascular?

a)

Oral

b)

Rectal

c)

Intramuscular

d)

Intra-arterial

16.

For extravascular administration, onset and duration are influenced by:

a)

Only renal clearance mechanisms

b)

Formulation/type of dosage form, route, physico-chemical properties, and other physiological variables

c)

Only receptor binding kinetics

d)

Only tissue biopsy sampling

17.

A limitation of extravascular administration is:

a)

Entire dose may not always reach general circulation

b)

No absorption phase occurs

c)

Entire dose always reaches general circulation

d)

Adverse reactions are always reversible

18.

Absorption is defined as the process by which a drug proceeds from the site of administration to:

a)

The receptor site only

b)

The site of measurement

c)

The liver only

d)

The nephron only

19.

Which is included as a physiological barrier to absorption?

a)

GI tract

b)

Bone marrow

c)

Retina

d)

Synovial fluid

20.

For an extravascular route, maximum concentration (Cmax) is reached when:

a)

Rate of elimination exceeds rate of absorption

b)

Rate of absorption equals rate of drug elimination

c)

Drug first appears in plasma

d)

Drug falls below MEC

21.

Distribution is defined as:

a)

Irreversible removal via kidneys

b)

Reversible transfer to/from site of measurement

c)

Only partitioning into fat

d)

Only movement from liver to bile

22.

Which organ is identified as the principal organ of drug metabolism?

a)

Brain

b)

Kidneys

c)

Liver

d)

Skin

23.

Drug removal via mother’s milk:

a)

Is the primary excretion route for mothers

b)

Is not significant for the mother, but can affect the infant if consumed in sufficient quantity

c)

Prevents infant exposure due to metabolism in milk

d)

Only applies to IV drugs

24.

Elimination is:

a)

Absorption + distribution

b)

Metabolism + excretion

c)

Distribution + absorption

d)

Biopharmaceutics + pharmacodynamics

25.

“First-pass effect” is also known as:

a)

Bioequivalence

b)

Presystemic metabolism

c)

Disposition

d)

Distribution

26.

Which of the following is the unit for the onset of action and the duration of action?

a)

mg/hr

c)

Hour

d)

hr-1

27.

It is challenging to measure drug concentration in a tissue following intravenous

administration.

a)

False

b)

True

28.

A drug molecule in urine can reenter the blood by a process known as tubular reabsorption.

a)

True

b)

False

29.

“Time for peak plasma level” is the time of maximum drug concentration and indicates the average rate of absorption.

a)

True

b)

False

30.

Intravascular administration has an absorption phase, so onset depends heavily on dissolution rate.

a)

True

b)

False

31.

A pharmacokinetic model is best defined as:

a)

A physical organ system that determines drug distribution

b)

A hypothesis expressed mathematically to describe a quantitative relationship

c)

A lab assay used to measure plasma concentrations

d)

A constant that cannot be estimated experimentally

32.

Which pairing is correct?

a)

Variable = constant for the drug; Parameter = experimental data

b)

Variable = experimental data; Parameter = constant estimated from data

c)

Variable = dependent only; Parameter = independent only

d)

Variable = assumption; Parameter = hypothesis

33.

In a typical plasma concentration–time profile, which is dependent?

a)

Time

b)

Dose

c)

Plasma concentration

d)

Route of administration

34.

Which statement is a limitation of PK models?

a)

Plasma drug concentration always predicts drug action

b)

A model never requires assumptions

c)

Genetic differences and disease state can modify drug response

d)

A model always fits every observation

35.

A compartment in compartmental PK is:

a)

A real anatomical organ

b)

A real fluid space

c)

Not a real anatomical area; a conceptual grouping of tissues with similar blood flow/affinity

d)

Always a closed system

36.

A drug is most consistent with a one-compartment open model when:

a)

Distribution equilibrium is reached at a finite time

b)

Rapid distribution equilibrium occurs essentially immediately; distribution vs elimination phases cannot be distinguished

c)

Elimination occurs only from the peripheral compartment

d)

There is always a biphasic decline on a semilog plot

37.

In the two-compartment model described, which would most likely be considered peripheral compartment?

a)

Blood and kidney

b)

Liver and kidney

c)

Cartilage and fatty tissue

d)

Blood and liver

38.

Which drug property is most likely to indicate determining whether a higher-compartment model is needed?

a)

Degree of plasma protein binding

b)

Distribution speed/property

c)

First-pass metabolism

d)

Renal clearance only

39.

Why is selecting the right compartment model and equation critical?

a)

Because AUC becomes independent of dose

b)

Wrong choices produce erroneous PK parameters and predictions

c)

Because distribution always occurs after elimination

d)

Because models eliminate the need for early sampling

40.

Before selecting a compartment model, you must have:

a)

Urine metabolite profiles only

b)

Plasma concentration vs time data

c)

Only tissue biopsy concentrations

d)

Only an assumed half-life

41.

Which approach aligns with the recommended strategy?

a)

Start with 3 compartments to avoid underfitting

b)

Start with 1 compartment; if fit is inadequate, move to 2+ compartments

c)

Choose a model solely based on the route of administration

d)

Choose a model without statistical analysis

42.

Why is collecting plasma samples early after IV administration emphasized?

a)

To increase Ka

b)

To ensure Cp0 is estimated accurately

c)

To avoid distribution equilibrium

d)

To eliminate the need for statistical analysis

43.

A model is a hypothesis using mathematical terms to describe a discrete quantitative relationship.

a)

True

b)

False

44.

According to the one-compartment model, drug concentrations will be in equilibrium throughout the body shortly after an ________ dose

a)

Intraperitoneal

b)

Intravenous bolus

c)

Oral solid

d)

Oral liquid

45.

The unique characteristic of a one-compartment model is that drug distribution equilibrium is attained very rapidly following the administration of a dose; this simply suggests that the amount and/or the concentration of drug, at a time, will be identical in all tissues and organs.

a)

True

b)

False

46.

Regarding a two-compartment model for intravenous bolus injection, a drug is always monitored in the blood, plasma or serum.

a)

True

b)

False

47.

According to mass balance consideration, an intravascular dose is equal to a sum of which of the following items? (Select all that apply).

a)

Amount at the absorption site

b)

Amount distributed in vascular tissues

c)

Amount in the body

d)

Amount metabolized

e)

Amount excreted

48.

In a Cp vs time plot, which is the dependent variable?

a)

Time

b)

Dose

c)

Plasma drug concentration

d)

Route of administration

49.

In a 2-compartment IV bolus model:

a)

α and β are micro rate constants

b)

α and β are hybrid rate constants

c)

α = elimination constant; β = distribution constant

d)

α = absorption constant; β = excretion constant

50.

Distribution equilibrium in a two compartment model is achieved when:

a)

Xc​=Xp​

b)

K10​=0

c)

Xc​K12​=Xp​K21​

d)

A=B